drugset / Trial / NCT05585606
Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke
RandomizedSequentialQuadruple-blindTreatment
Summary
A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study of the Safety and Neuroprotective Capacity of Scp776 in Subjects Undergoing Endovascular Thrombectomy for Acute Ischemic Stroke
Timeline
- Start
- 2022-10-19
- Primary completion
- 2025-09-15
- Completion
- 2025-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | scp776 | Unknown | 1.9 mg/kg | Intravenous |
| Subject | scp776 | Unknown | 3.8 mg/kg | Intravenous |
| Subject | scp776 | Unknown | 4.8 mg/kg | Intravenous |